Join
Live feed
·
PRReleasevia Quantisnow
Biolase Inc. logo

BIOLASE DELIVERS 24% REVENUE GROWTH IN 2022 AS GO-TO-MARKET STRATEGIES GAIN MOMENTUM; GUIDES FOR AT LEAST 25% REVENUE GROWTH AND PROFITABILITY IN 2023

ByQuantisnow·Wall Street's wire, on your screen.
BIOL· Biolase Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BIOL (Biolase Inc.) and more on Quantisnow.